I help biotechnology companies build stronger platforms, make better R&D decisions and
accelerate therapeutic development.
With more than 25 years of experience in pharmaceutical and biotechnology R&D, I provide independent scientific and strategic support from early platform development and candidate selection through preclinical and translational development to clinical-stage programmes.
My experience spans RNA therapeutics and drug delivery, small molecules, biologics and microbiome therapeutics, across a broad range of therapeutic areas.
How I Can Help
Fractional Executive Leadership
Senior scientific leadership, R&D strategy and board advisory support when you need it.
Platform & Pipeline Strategy
Assessing technologies, defining opportunities and building focused development
pipelines.
Programme & Translational Strategy
Turning promising science into robust, evidence-driven development programmes.
RNA Therapeutics & Advanced Modalities
Specialist expertise in RNA therapeutics, drug delivery and platform development.
Externalised R&D
Selecting and overseeing CROs, CDMOs and specialist external partners.
Scientific & Technical Due Diligence
Independent assessment of technologies, programmes, risks and development opportunities.
Experience Across Biotechnology R&D
I have held CSO, CTO and senior scientific leadership roles at Athernal Bio, CureVac, Atriva Therapeutics, MRM Health and Ethris, with earlier experience at Pfizer.
My career has combined scientific discovery, technology and platform development, therapeutic programme leadership and the practical challenges of progressing innovative medicines towards the clinic.
Independent Support, Tailored to Your Needs
I work with biotechnology companies, founders, management teams, boards and investors internationally. Engagements range from focused scientific or strategic projects to ongoing advisory and fractional leadership roles.